Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid

Journal of Microencapsulation

Volumn 18, Issue 6, 2001, Pages 723-732

  Raghuvanshi, R J ^a   Mistra, A ^a   Talwar, G P ^a   Levy, R J ^a   Labhasetwar, V ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antibody response; Polymer; Sustained release; Vaccine

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; COPOLYMER; IMMUNOGLOBULIN G; NANOPARTICLE; POLYLACTIC POLYGLYCOLIC ACID COPOLYMER; POLYMER; TETANUS ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; INFECTION CONTROL; INJECTION; MEASUREMENT; MOLECULAR WEIGHT; NONHUMAN; RAT;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; CAPSULES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG SYNERGISM; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; LACTIC ACID; NANOTECHNOLOGY; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, WISTAR; TETANUS TOXOID;

EID: 0034777178     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.1080/02652040110055261     Document Type: Article

References (23)

1. Adjuvants: Current status, clinical perspectives and future prospects
2. Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response
3. Interaction between polyalkylycyanoacrylate nanoparticles and peritoneal macrophages: MTT metabolism, NBT reduction, and NO production
4. Immune response with biodegradable nanospheres and alum: Studies in rabbits using staphylococcal enterotoxin B-toxoid
5. Biodegradable microspheres: Vaccine delivery system for oral immunization
6. New advances in vaccine delivery systems
7. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid
8. Aluminium compounds as vaccine adjuvants
9. Adjuvants for human vaccines-current status, problems and future prospects
10. In vivo distribution of radioactivity in mice after injection of biodegradable polymer microspheres containing 14C-labeled tetanus toxoid
11. The role of adjuvants and delivery systems in modulation of immune response to vaccines
12. Synthetic immunomodulators and synthetic vaccines
13. Protection against vaginal SIV transmission with microencapsulated vaccine
14. Controlled release microparticles for vaccine development
15. Recent advances in vaccine adjuvants: The development of MF59 emulsion and polymeric microparticles
16. Formulation and evaluation of biodegradable microspheres for controlled release of tetanus toxoid
17. Stabilization of dichloromethane-induced protein denaturation during microencapsulation
18. Controlled release microparticles as a single dose hepatitis B vaccine: Evaluation of immunogenicity in mice
19. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine
20. Biodegradable delivery system for a birth control vaccine: Immunogenicity studies in rats and monkeys
21. Vaccine delivery systems: Potential methods for use in antifertility vaccines
22. Studies on antibody production. III. The alum granoloma
23. Controlled delivery of antigens and adjuvants in vaccine development